Advisory Board
The Amgen Bioprocessing Center Advisory Board (ABCAB) consists of scientists, engineers, academics and corporate executives who provide support and advice to KGI's Amgen Bioprocessing Center.
Sid Advant, PhD
Principal
Tunnell Consulting
Ashraf Amanullah, PhD
Associate Director and Principal Engineer
Genentech, Inc.
Dawn Applegate, PhD
President and Chief Executive Officer
RegeneMed
Mark Applegate, PhD
Executive Director, Manufacturing
Vical, Inc.
John Aunins, PhD
Executive Scientific Director
Merck & Co. Inc.
Robert Baffi, PhD
Senior Vice President, Technical Operations
BioMarin
Kevin M. Bailey, PhD
Vice President, Preclinicial Manufacturing and Process Development
Regeneron Pharmaceuticals, Inc.
Harvey Blanch, PhD
Merck Professor of Biochemical Engineering
University of California at Berkeley
Fabrizio Bonanni, ScD
Executive Vice President, Operations
Amgen Inc.
Anthony Bright, PhD
Professor, Engineering Department
Harvey Mudd College
Manuel Carrondo, PhD
Professor and Chief Executive Officer
IBET
Charles L. Cooney, PhD
Professor of Chemical and Biochemical Engineering and Faculty Director
Massachusetts Institute of Technology
Larry A. Couture, PhD
Senior Vice President, Center for Applied Technology Development
City of Hope National Medical Center
Iman Famili, PhD
Sr. Director, R&D
GT Life Sciences, Inc.
Katherine Farrell, PhD
Former Director of Global Clinical Supply Chain, Amgen
Independent Consultant
Dennis Fenton, PhD
Former Executive Vice President, Amgen
Bob Garrahy
Vice President of Sales & Marketing, Broadley-James
Joydeep Goswami, PhD
Vice President, Stem Cells & Regenerative Medicine
Invitrogen
S. Sam Guhan, PhD
Director of Process Development
Amgen Inc.
Robert Johnson, PhD
Director, Recombinant and Analytical Development
Amylin Pharmaceuticals, Inc.
Brian Kelley, PhD
Vice President, Bioprocess Development
Genentech, Inc.
Peter Kramer, PhD
Director, Manufacturing Sciences
Bayer HealthCare, LLC
James Leung, PhD
Former Vice President Biotechology, Ipsen
Independent Consultant
Karen McDonald, PhD
Associate Dean of Research and Graduate Studies
University of California at Davis
Steven Perry
Vice President, Manufacturing Operations
Cytovance Biologics
David Rozzell, PhD
CEO
Sustainable Chemistry Solutions
Thomas Ryll, PhD
Director, Cell Culture Development
Biogen Idec, Inc.
Eugene Schaefer, ScD
Senior Director, Pharmaceutical Development Systems
Johnson & Johnson BIO Centocor
Christopher H. Schilling, PhD
President and Chief Scientific Officer
Genomatica, Inc.
Mr. Thomas E. Smart
Chairman and Chief Executive Officer
AnaptysBio, Inc.
Mani Subramanian, PhD
Professor and Director
University of Iowa
Rob Tenerowicz
Vice President, Operations and BioDefense
XOMA (US) LLC
Jorg Thommes, PhD
Senior Director, Technical Development
Biogen Idec, Inc.
David Vetterlein, PhD
Principal Consultant
Alliance BioProcess Consulting
Marcio Voloch, PhD
Vice President, Process Development
Shire Human Genetic Therapies, Inc.
Daniel I.C. Wang, PhD
Institute Professor, Chemical Engineering
Massachusetts Institute of Technology
James A. Wilkins, PhD
Senior Scientist and Group Leader Technology Assessment
Genentech, Inc.
Grant Yonehiro
CBO & Senior Vice President Development Programs
Maxygen